BridgeBio Pharma (BBIO) PT Raised to $60 at Mizuho
Tweet
Share
E-mailGet Alerts BBIO Hot Sheet
Price: $76.60 -2.64%
Rating Summary:
25 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Rating Summary:
25 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Join SI Premium – FREE
Mizuho analyst Salim Syed raised the price target on BridgeBio Pharma (NASDAQ: BBIO) to $60.00 (from $53.00) while maintaining a Outperform rating.
You May Also Be Interested In
- BridgeBio doses first patient in Phase 3b/4 acoramidis heart study
- Macquarie Downgrades Foshan Haitian Flavouring (603288:CH) to Neutral
- Minimax Group Inc (100:HK) PT Raised to HK$804 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
